Recessive Dystrophic Epidermolysis Bullosa
📧 Sign up to get email alerts when something new happens for Recessive Dystrophic Epidermolysis Bullosa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
A Stanford University-sponsored clinical trial aims to characterize patients with recessive dystrophic epidermolysis bullosa and is currentl…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin [Phase 2]
Phase 2 clinical trial investigating COL7A1 gene therapy to reduce recurrence of squamous cell carcinoma in skin affected by recessive dystr…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
A clinical trial update indicates Phase 1/Phase 2 studies are investigating intravenous immunoglobulin–based therapy targeting collagen VII …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating GMEB-SASS, a gene-modified skin substitute, for treating recessive dystrophic epidermolysis bullosa, i…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa [Phase 3]
Phase 3 study evaluating KB803 versus matched placebo in Dystrophic Epidermolysis Bullosa is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients [Phase 3]
A Phase 3b trial of EB-101 for recessive dystrophic epidermolysis bullosa (DEB) in new and previously EB-101 treated patients is active but …
-
CLINICAL_TRIALS research · 2025-06-09Clinical Trial Update: Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) [Phase 1, Phase 2]
A clinical trial update evaluating efgartigimod alfa (Vyvgart) to treat bullous diseases by targeting collagen VII antibodies in Epidermolys…
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
Clinical trial update on mesenchymal stromal cells for adults with Recessive Dystrophic Epidermolysis Bullosa (Phase 1/Phase 2).
-
CLINICAL_TRIALS research · 2014-05-16Clinical Trial Update: Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
This update describes the characteristics of adult patients with recessive dystrophic epidermolysis bullosa.